Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New Triple-Action therapy takes aim at Hard-to-Treat cancers

NCT ID NCT04389281

First seen Jan 05, 2026 · Last updated May 23, 2026 · Updated 26 times

Summary

This early-stage trial is testing a new treatment called X-PACT for people with advanced head and neck cancer, breast cancer, soft tissue sarcoma, or melanoma. The treatment involves injecting a special drug and tiny light-producing particles directly into the tumor, then exposing it to X-rays to activate the drug and kill cancer cells. The main goal is to check if the treatment is safe, and it is open to adults whose cancer has not responded to standard therapies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Duke University

    RECRUITING

    Durham, North Carolina, 27710, United States

    Contact

    Contact

  • Levine Cancer Institute

    RECRUITING

    Charlotte, North Carolina, 28204, United States

    Contact

    Contact

  • Prisma Health

    RECRUITING

    Greenville, South Carolina, 29605, United States

    Contact

  • Sibley Hospital - Johns Hopkins University

    RECRUITING

    Washington D.C., District of Columbia, 20016, United States

    Contact

Conditions

Explore the condition pages connected to this study.